Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiumin Yang

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|April 4, 2020
"Efficacy and safety of Liangxue Jiedu decoction for the treatment of progressive psoriasis vulgaris: a multicenter, randomized, controlled study"Liyun Sun, Tiantian Li, Dongmei Zhou, et al.
Journal of the American Academy of Dermatology|April 5, 2023
A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areataCheng Zhou, Xiumin Yang, Bin Yang, et al.
Journal of the American Academy of Dermatology|September 21, 2025
Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trialCheng Zhou, Chunjun Yang, Weixin Fan, et al.
Journal of the American Academy of Dermatology|April 10, 2025
Efficacy and safety of SYSA1902 versus reference ustekinumab in moderate-to-severe plaque psoriasis: A multicenter, randomized, phase III studyLixin Xia, Guoying Miao, Xiumin Yang, et al.
Chinese Medical Journal|September 8, 2025
Efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled trialKun Huang, Songmei Geng, Xiaohua Tao, et al.
Dermatology (Basel, Switzerland)|December 22, 2020
Tazarotene/Betamethasone Dipropionate Cream in Patients with Plaque Psoriasis: Results of a Prospective, Multicenter, Observational StudyChunxia He, Hongzhong Jin, Xiguang Liu, et al.
JAMA Dermatology|September 25, 2024
Efficacy and Safety of Crisugabalin (HSK16149) in Adults with Postherpetic Neuralgia: A Phase 3 Randomized Clinical TrialDaying Zhang, Tiechi Lei, Lanying Qin, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|April 4, 2020
"Efficacy and safety of Liangxue Jiedu decoction for the treatment of progressive psoriasis vulgaris: a multicenter, randomized, controlled study"Liyun Sun, Tiantian Li, Dongmei Zhou, et al.
Journal of the American Academy of Dermatology|April 5, 2023
A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areataCheng Zhou, Xiumin Yang, Bin Yang, et al.
Journal of the American Academy of Dermatology|September 21, 2025
Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trialCheng Zhou, Chunjun Yang, Weixin Fan, et al.
Journal of the American Academy of Dermatology|April 10, 2025
Efficacy and safety of SYSA1902 versus reference ustekinumab in moderate-to-severe plaque psoriasis: A multicenter, randomized, phase III studyLixin Xia, Guoying Miao, Xiumin Yang, et al.
Chinese Medical Journal|September 8, 2025
Efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled trialKun Huang, Songmei Geng, Xiaohua Tao, et al.
Dermatology (Basel, Switzerland)|December 22, 2020
Tazarotene/Betamethasone Dipropionate Cream in Patients with Plaque Psoriasis: Results of a Prospective, Multicenter, Observational StudyChunxia He, Hongzhong Jin, Xiguang Liu, et al.
JAMA Dermatology|September 25, 2024
Efficacy and Safety of Crisugabalin (HSK16149) in Adults with Postherpetic Neuralgia: A Phase 3 Randomized Clinical TrialDaying Zhang, Tiechi Lei, Lanying Qin, et al.
Pageof 7